Inventor · disambiguated record
Craig D. Boyle
Also filed as: BOYLE CRAIG · BOYLE CRAIG D
29 granted patents·9 pending applications·516 citations·filing 1996–2012
97Inventor score
Top patents by PatentIndex Score
38 records- 0198US6821978B2Xanthine phosphodiesterase V inhibitorsSCHERING CORP·Filed 2001·Granted Nov 23, 2004·140 cites·34 claims
- 0294US6630475B2Adenosine A2a receptor antagonistsSCHERING CORP·Filed 2001·Granted Oct 7, 2003·53 cites·17 claims
- 0393US5889006AMuscarinic antagonistsSCHERING CORP·Filed 1996·Granted Mar 30, 1999·123 cites·18 claims
- 0490US8907095B2Bicyclic heterocycle derivatives and their use as modulators of the activity of GPR119XIA YAN·Filed 2008·Granted Dec 9, 2014·23 cites·14 claims
- 0587US6897217B22-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonistsSCHERING CORP·Filed 2004·Granted May 24, 2005·25 cites·21 claims
- 0684US7572802B27-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amineSCHERING CORP·Filed 2006·Granted Aug 11, 2009·7 cites·15 claims
- 0783US8815876B2Bicyclic heterocycle derivatives and methods of use thereofNEELAMKAVIL SANTHOSH FRANCIS·Filed 2009·Granted Aug 26, 2014·7 cites·16 claims
- 0883US6444687B1Substituted imidazole neuropeptide Y Y5 receptor antagonistsSCHERING CORP·Filed 2000·Granted Sep 3, 2002·18 cites·7 claims
- 0982US6916811B2Adenosine A2a receptor antagonistsSCHERING CORP·Filed 2002·Granted Jul 12, 2005·17 cites·9 claims
- 1082US6043255AMuscarinic antagonistsSCHERING CORP·Filed 1999·Granted Mar 28, 2000·50 cites·16 claims
- 1181US7531544B2Xanthine phosphodiesterase V inhibitorsSCHERING CORP·Filed 2007·Granted May 12, 2009·2 cites·3 claims
- 1280US7368449B22-alkynyl- and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonistsSCHERING CORP·Filed 2005·Granted May 6, 2008·4 cites·16 claims
- 1378US7465740B22-heteroaryl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonistsSCHERING CORP·Filed 2006·Granted Dec 16, 2008·3 cites·17 claims
- 1476US8318751B2Pyrimidinone derivatives and methods of use thereofBOYLE CRAIG D·Filed 2008·Granted Nov 27, 2012·3 cites·42 claims
- 1576US6890936B2Muscarinic antagonistsSCHERING CORP·Filed 2003·Granted May 10, 2005·9 cites·26 claims
- 1675US8389532B27-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-E]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amineBOYLE CRAIG D·Filed 2009·Granted Mar 5, 2013·2 cites·4 claims
- 1774US7709492B2Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonistsSCHERING CORP·Filed 2005·Granted May 4, 2010·2 cites·20 claims
- 1874US6897216B2Adenosine A2a receptor antagonistsSCHERING CORP·Filed 2003·Granted May 24, 2005·5 cites·6 claims
- 1973US6632828B2Substituted imidazole neuropeptide Y Y5 receptor antagonistsSCHERING CORP·Filed 2002·Granted Oct 14, 2003·6 cites·8 claims
- 2072USRE44205EAdenosine A2a receptor antagonistsNEUSTADT BERNARD R·Filed 2012·Granted May 7, 2013·2 cites·21 claims
- 2172US7268141B2Xanthine phosphodiesterase V inhibitorsSCHERING CORP·Filed 2004·Granted Sep 11, 2007·4 cites·22 claims
- 2271US8822480B2Bicyclic heterocycle derivatives and use thereof as GPR119 modulatorsNEELAMKAVIL SANTHOSH FRANCIS·Filed 2009·Granted Sep 2, 2014·1 cites·19 claims
- 2370US8580807B2Bicyclic piperidine and piperazine derivatives as GPCR modulators for the treatment of obesity, diabetes and other metabolic disordersBOYLE CRAIG D·Filed 2010·Granted Nov 12, 2013·2 cites·17 claims
- 2466US7192962B2Xanthine phosphodiesterase V inhibitor polymorphsSCHERING CORP·Filed 2003·Granted Mar 20, 2007·5 cites·26 claims
- 2564US7312223B2Metabolite of xanthine Phosphodiesterase 5 inhibitor and derivatives thereof useful for treatment of erectile dysfunctionSCHERING CORP·Filed 2004·Granted Dec 25, 2007·3 cites·15 claims
- 2661US2005075349A1Xanthine phosphodiesterase V inhibitorsSCHERING CORP·Filed 2004·Application pending·0 cites
- 2760US2004229885A1Xanthine phosphodiesterase V inhibitorsSCHERING CORP·Filed 2004·Application pending·0 cites
- 2859US2005182077A1Xanthine phosphodiesterase V inhibitorsSCHERING CORP·Filed 2005·Application pending·0 cites
- 2951US2011065671A1Bicyclic heterocycle derivatives and use thereof as gpr119 modulatorsHARRIS JOEL M·Filed 2009·Application pending·0 cites
- 3050US2010113330A1Tetrahydropyrido[4,3-d]pyrimidinone derivatives and methods of use thereofSCHERING CORP·Filed 2008·Application pending·0 cites
- 3150US2011129542A1Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1SCHERING CORP·Filed 2008·Application pending·0 cites
- 3250US2011118286A1Bicyclic heterocycle derivatives and their use as gpcr modulatorsNEELAMKAVIL SANTHOSH FRANCIS·Filed 2009·Application pending·0 cites
- 3348US8466149B26-substituted sulfonyl azabicyclo[3.2.1]octanes useful to inhibit 11β-hydroxysteroid dehydrogenase type-IBOYLE CRAIG D·Filed 2008·Granted Jun 18, 2013·0 cites·4 claims
- 3448US2010190687A1Pyrimidinone derivatives and methods of use thereofBOYLE CRAIG D·Filed 2008·Application pending·0 cites
- 3546US8604195B2Substituted bicyclic piperidinyl- and piperazinyl-sulfonamides useful to inhibit 11β-hydroxysteroid dehydrogenase type-1SHAH UNMESH·Filed 2008·Granted Dec 10, 2013·0 cites·2 claims
- 3639US9161924B2Factor IXa inhibitorsBOYLE CRAIG·Filed 2012·Granted Oct 20, 2015·0 cites·14 claims
- 3738US9301929B2Substituted biaryl derivatives and methods of use thereofBOYLE CRAIG D·Filed 2010·Granted Apr 5, 2016·0 cites·10 claims
- 3833US2012040975A1Bridged bicyclic heterocycle derivatives and methods of use thereofNEELAMKAVIL SANTHOSH FRANCIS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Craig D. Boyle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →